Back to AERIView Full LandscapeView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
3 competitors in Open Angle Glaucoma
ALCOX.PANCX 470 0.1%
Phase 3ALCOX.PANCX 470 0.065% (initial phase of trial)
Phase 3ABBVBimatoprost (SR)
Phase 3Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA11/19/2019
Rhokiinsa
Reduction of elevated intraocular pressure (IOP) in adult patients with primary open-angle glaucoma or ocular hypertension.
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
Timolol maleate Ophthalmic Solution 0.5% BIDPhase 3
Ocular Hypertension
AR-13324 Ophthalmic Solution 0.02%Phase 3
Ocular Hypertension
Latanoprost ophthalmic solution 0.005%Phase 3
Ocular Hypertension
Netarsudil ophthalmic solution 0.02%Phase 3
Primary Open Angle Glaucoma
0.003% AR-15512 ophthalmic solutionPhase 3
Dry Eye Disease
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts